Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR
  • Request More Information
  • Journalists
  • GDPR

Verix Upgrades Platform with "GenAI Database Explorer," Providing Actionable Insights on Commercial Pharma Data


News provided by

Verix

28 Mar, 2024, 14:00 IST

Share this article

Share toX

Share this article

Share toX

The new LLM-based capability allows pharmaceutical sales representatives and commercial teams to navigate complex data assets intuitively, using natural language, providing accessible and actionable insights for sales execution.

SANTA CLARA, Calif., March 28, 2024 /PRNewswire/ -- Verix, a leading  AI-powered pharmaceutical commercial operations enhancement platform provider, announced today the launch of its "GenAI Database Explorer," a capability designed to revolutionize the exploration of commercial pharmaceutical data. Integrated with Tovana, this capability enables users to explore data intuitively using natural language, marking a significant leap forward in making complex data insights more accessible.

Verix's platform, Tovana, uses machine learning to derive insights from commercial data assets, for pharmaceutical sales teams. The insights help sales teams better target, engage, and influence sales and adoption with healthcare providers, understanding their behavior, preferences, and needs, as well as their patients. The new GenAI Database Explorer will help sales reps query the data using natural language to craft compelling sales strategies, tailor their approach to their targets, maximize HCP engagement, and analyze their performances effortlessly.

Integrating Gen AI Database Explorer with Tovana enables users to fully leverage the platform's robust auto-data foundation to extract actionable insights without prior familiarity with data structures using the latest NLP technology per higher compliance standards.

"Our GenAI Database Explorer empowers users to easily access valuable information and generate insights catering to their own business needs. It increases data exploitation, informed decision-making, and helps field teams better prepare for their next engagement," said Doron Aspitz, CEO of Verix. We have already started receiving excellent feedback from our pilot customers and look forward to rolling this out to all our customers and clients today."

Shahar Cohen, CTO, added, "By leveraging recent LLM (Large Language Models) progress, along with our core expertise, our GenAI Database Explorer provides an exploration experience similar to that of an AI Chatbot while only providing accurate and relevant answers based on our database."

About Verix

Verix provides an AI-based platform that enhances commercial optimization for Pharmaceutical companies. The platform uses a plethora of data and cutting-edge technology to optimize strategy development and effective execution. Verix's platform embeds deep learning with abundant domain expertise to optimize essential processes such as HCP targeting, precision forecasting, channel optimization, patient discovery, and more in a consistent and continuous manner to keep up with the dynamic nature of today's life sciences market. Verix's innovative Platform enables Fortune 500 pharmaceutical organizations worldwide to leverage their data and accelerate brand performance in a flexible, accurate, fast, and easy-to-use manner. For more information, please visit www.verix.com.

Media Contact

Elya Cowland
Gova10 for Verix
[email protected]

SOURCE Verix

Modal title

Also from this source

Verix Secures U.S. Patent for Dynamic Code Technology Enabling Intelligent Automation in its Flagship Tovana™ Platform

Verix, a leader in life sciences commercial optimization, announced today that the United States Patent and Trademark Office (USPTO) has granted a...

More Releases From This Source

Explore

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

Computer & Electronics

Computer & Electronics

Artificial Intelligence

Artificial Intelligence

News Releases in Similar Topics

Contact PR Newswire

  • +972-77-2005042
    from 8 AM - 11 PM IL

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Csezh
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italie
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+972-77-2005042
from 8 AM - 11 PM IL
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.